Related Experiment Video
Updated: Aug 15, 2026

Multi-photon Intracellular Sodium Imaging Combined with UV-mediated Focal Uncaging of Glutamate in CA1 Pyramidal Neurons
Published on: October 8, 2014
DMCM: a potent convulsive benzodiazepine receptor ligand
Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) causes seizures by affecting GABA/benzodiazepine receptors. Certain antagonists and medications block DMCM-induced seizures, differentiating its mechanism from other convulsants.
Area of Science:
- Neuropharmacology
- GABAergic system research
- Epilepsy mechanisms
Background:
- Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate (DMCM) is a potent convulsant.
- DMCM exhibits high affinity for benzodiazepine (BZ) binding sites.
Purpose of the Study:
- To compare compounds for their ability to prevent seizures induced by DMCM.
- To investigate the mechanism of DMCM-induced seizures in relation to the GABA/BZ receptor-chloride channel complex.
Main Methods:
- DMCM-induced seizures were induced and antagonized.
- Compounds tested included BZ receptor antagonists, benzodiazepines, and other antiepileptic drugs.
- Comparative analysis of seizure prevention efficacy against DMCM and pentylenetetrazol (PTZ).
Main Results:
- Benzodiazepine receptor antagonists selectively antagonized DMCM-induced seizures, unlike PTZ-induced seizures.
- Standard antiepileptic drugs (diazepam, clonazepam, valproate, etc.) antagonized both DMCM and PTZ seizures.
- Valproate and baclofen showed significantly higher potency against DMCM seizures compared to PTZ seizures.
Conclusions:
- DMCM-induced seizures likely result from inverse agonism at the GABA/BZ receptor-chloride channel complex.
- DMCM's mechanism of action is distinct from GABA receptor blockers.
- Specific BZ receptor antagonists and certain antiepileptic drugs can effectively counteract DMCM's convulsant effects.
More Related Videos
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Anxiolytic Drugs: Benzodiazepines and Buspirone
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

